Amarin Corp Plc (AMRN)

[couldbebetter]

Will Lar, Hardly a surprise since last quarters conference call where JT
outlined the plan for Europe. Remember, it is just hiring a skelton
crew to negotiate pricing on Vascepa with various countries. Note, they
have no distribution. In other words JT may hire or JV a sales force, or
it may all be a "ruse" to keep the paperwork moving along until AMRN
either announces a BO or a JV partner.

In past presentations, the ones where JT said 80 million people in
Europe had CVD and that number was growing by 10 or 11 million more
per...that would be some 100 million people with CVD in a couple of
years. Vascepa is a safe and effective CVD drug. Maybe to get the
best deals with socialist governments the price would be $1000 a year.
Then, for each 1% of Europe Vascepa would bring in $1 billion a year.
Just 5% would be $5 billion in revenues. (Not that BP would ever pay
up for that.) But even $12 offered would be better than where its
at now! What if Vascepa is protective of COVID-19? Would BP exploit
that? You bet. Would they pay extra for that chance? No way!